- Home
- DRUG vs FNGR Comparison
DRUG vs FNGR Comparison
Compare DRUG & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- FNGR
- Stock Information
- Founded
- DRUG 2019
- FNGR 2016
- Country
- DRUG United States
- FNGR Singapore
- Employees
- DRUG N/A
- FNGR N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- FNGR Computer Software: Prepackaged Software
- Sector
- DRUG Health Care
- FNGR Technology
- Exchange
- DRUG Nasdaq
- FNGR Nasdaq
- Market Cap
- DRUG 233.2M
- FNGR 259.4M
- IPO Year
- DRUG N/A
- FNGR N/A
- Fundamental
- Price
- DRUG $25.95
- FNGR $3.02
- Analyst Decision
- DRUG Strong Buy
- FNGR
- Analyst Count
- DRUG 6
- FNGR 0
- Target Price
- DRUG $83.25
- FNGR N/A
- AVG Volume (30 Days)
- DRUG 29.2K
- FNGR 1.3M
- Earning Date
- DRUG 05-15-2025
- FNGR 05-29-2025
- Dividend Yield
- DRUG N/A
- FNGR N/A
- EPS Growth
- DRUG N/A
- FNGR N/A
- EPS
- DRUG N/A
- FNGR N/A
- Revenue
- DRUG N/A
- FNGR $35,607,614.00
- Revenue This Year
- DRUG N/A
- FNGR N/A
- Revenue Next Year
- DRUG N/A
- FNGR N/A
- P/E Ratio
- DRUG N/A
- FNGR N/A
- Revenue Growth
- DRUG N/A
- FNGR N/A
- 52 Week Low
- DRUG $0.93
- FNGR $1.03
- 52 Week High
- DRUG $79.02
- FNGR $5.20
- Technical
- Relative Strength Index (RSI)
- DRUG 30.05
- FNGR 46.50
- Support Level
- DRUG $26.30
- FNGR $2.50
- Resistance Level
- DRUG $31.20
- FNGR $4.38
- Average True Range (ATR)
- DRUG 2.50
- FNGR 0.57
- MACD
- DRUG -0.55
- FNGR -0.18
- Stochastic Oscillator
- DRUG 5.59
- FNGR 19.26
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.